Dr Ashwin Venkataraman is a Clinical Research Fellow at the Division of Brain Sciences, Imperial College London.
He is currently working with Professor Paul Matthews with a focus on brain Positron Emission Tomography (PET) and Magnetic Resonance (MRI) imaging in neurodegeneration and conducting the MINDMAPS-AD study.
Prior to this he was an Alzheimer's Research UK Clinical Fellow at the Neuropsychopharmacology Unit at Imperial College London working on how alcohol adds to amyloid deposition, and investigating a novel Imidazoline-2 receptor radioligand for Alzheimer's disease.
He is a Member of the Royal College of Psychiatrists. Before this he was an NIHR Academic Clinical Fellow, Academic Foundation Programme Doctor, and graduated from University College London Medical School.
Venkataraman A, Perry R, Malhotra P, Young Onset Dementia, Reference Module in Neuroscience and Biobehavioral Psychology
et al., 2018, First evaluation of PET-based human biodistribution and radiation dosimetry of C-11-BU99008, a tracer for imaging the imidazoline(2) binding site, Ejnmmi Research, Vol:8, ISSN:2191-219X
et al., 2017, Alcohol and Alzheimer's Disease-Does Alcohol Dependence Contribute to Beta-Amyloid Deposition, Neuroinflammation and Neurodegeneration in Alzheimer's Disease? (2016), Alcohol and Alcoholism, Vol:52, ISSN:0735-0414, Pages:158-158